Behavioral Health

Family, Work, and Mental Health Among Leading Factors Impacting Sleep in Adults

For many Americans, a good night’s sleep is easier said than done. According to a survey from the American Academy of Sleep Medicine, the pressures of daily life impact how well adults sleep. Topping the list, nearly half of adults (45%) say that family responsibilities have a major or moderate […]

Behavioral Health, Product News

Get Better Sleep With Ultrasound Patch That Boosts REM Rest

In a sleep management breakthrough, a University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication. The technology, called NEUSLeeP, is a soft, wearable device that uses gentle ultrasound waves and electrodes to stimulate deep brain […]

Narcolepsy, Pharmacological

Lundbeck Receives FDA Fast Track Designation for Lu Ah69593 Orexin 2 Receptor Agonist

Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company’s lead oral orexin 2 receptor agonist and one of several investigational compounds in Lundbeck’s development portfolio for sleep-wake disorders. Lu AH69593 was discovered by Lundbeck and it is presently in […]

Narcolepsy, Pharmacological

Takeda’s ORZEYFUL Approved in China for Narcolepsy Type 1

Takeda China announced that the National Medical Products Administration of China has approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1) in adolescents aged 16 years and older and adults. Oveporexton is the first oral orexin receptor 2 (OX2R)-selective agonist approved in China and is the […]